Diagnostic anti-porcine cereal Valley virus antibodies pairs and antigens for animal health (animal infectious disease ) testing in ELISA test,competitive ELISA test, blocking ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), and immunonephelometry
Catalog Number: GMP-AD-Pig-16
Definition of the disease: The porcine epidemic diarrhea virus (PEDV) causes an acute and highly contagious enteric disease characterized by severe enteritis, vomiting, watery diarrhea, and a high mortality rate in seronegative neonatal piglets. In the last few years, PED had a large economic impact on the swine industries in Asia and the US, and in 2014, the PEDV also re-emerged in Europe. Two main PEDV variants circulate worldwide but only the S INDEL variant, considered a mild strain, is spreading in Europe. To gain insights into the pathogenicity of this variant, its viral load and temporal shedding pattern were evaluated in piglets from infected farms. Quantitative real-time PCR (qPCR) targeting the spike gene, was validated according to the minimum information for quantitative real-time PCR experiments guidelines. The qPCR was applied to longitudinal studies conducted in four swine farms naturally infected with the PEDV S INDEL variant. Clinical data, fecal swabs, and blood samples were collected from 103 piglets at 15–30-day intervals for 2–5 months. On all four farms, diarrhea was observed in sows during gestation and in farrowing units, and the mortality rates of piglets were 18, 25, 30, and 35%. Different clinical pictures (0-50% of diarrhea positivity), viral titer levels (mean 5.3-7.2 log10 genome copies/mL), and antibody conditions (30-80% of positivity) were registered among sows on the four farms. The percentage of qPCR positive piglets varied greatly from the beginning (63–100%) to the end (0%) of the infection course. Clinical signs were present in 96% of the qPCR positive animals. Viral loads ranged from 8.5 log10 to 4 log10 genome copies/mL in suckling pigs at 3–6 days of age and were not statistically different among farms, despite the different patterns observed in sows. After 2–3 weeks, only a few piglets still showed detectable viral levels and clinical signs, and they developed antibody responses. Moreover, co-infections with other pathogens and biosecurity procedures limiting the circulation of the virus could have influenced the severity of PED infection. QPCR and clinical data were useful in understanding the dynamics of PEDV infections and, therefore, in implementing appropriate control measures.
Genemedi produces core animal health diagnostic ingredients-validated antibodies pairs Mouse anti-porcine cereal Valley virus monoclonal antibodies and porcine cereal Valley virus antigens for rapid test kit of animal infectious disease with porcine cereal Valley virus to evaluate the animal health of Pig.
The paired antibodies are both monoclonal antibody(mab).
All the antibodies and antiges of animal disease test are suitable for in functional ELISA, and other immunoassays in dignostics.The antibody can act as a capture antibody and detection antibody. Antigens are validated as positive control materials.
Order information
Catalog No. (1~4, 4 antibodies in pairs) |
Size | Price(In USD) | Qty (Quantity) | Sum(In USD) |
---|---|---|---|---|
GMP-AD-Pig-16Ab-1 | Size:1mg | 3090 | ||
GMP-AD-Pig-16Ab-1 | Size:10mg | 21935 | ||
GMP-AD-Pig-16Ab-1 | Size:100mg | 148000 | ||
GMP-AD-Pig-16Ab-2 | Size:1mg | 3090 | ||
GMP-AD-Pig-16Ab-2 | Size:10mg | 21935 | ||
GMP-AD-Pig-16Ab-2 | Size:100mg | 148000 | ||
GMP-AD-Pig-16Ab-3 | Size:1mg | 3090 | ||
GMP-AD-Pig-16Ab-3 | Size:10mg | 21935 | ||
GMP-AD-Pig-16Ab-3 | Size:100mg | 148000 | ||
GMP-AD-Pig-16Ab-4 | Size:1mg | 3090 | ||
GMP-AD-Pig-16Ab-4 | Size:10mg | 21935 | ||
GMP-AD-Pig-16Ab-4 | Size:100mg | 148000 | ||
GMP-AD-Pig-16Ag-1 | Size:1mg | 3090 | ||
GMP-AD-Pig-16Ag-1 | Size:10mg | 21935 | ||
GMP-AD-Pig-16Ag-1 | Size:100mg | 148000 | ||
GMP-AD-Pig-16Ag-2 | Size:1mg | 3090 | ||
GMP-AD-Pig-16Ag-2 | Size:10mg | 21935 | ||
GMP-AD-Pig-16Ag-2 | Size:100mg | 148000 | ||
Shipping Cost: | 760.00 | |||
Total: | ||||
Description
GMP-AD-Pig-16Ab, GMP-AD-Pig-16Ag
Cat No. | GMP-AD-Pig-16Ab |
Antigens | porcine cereal Valley virus |
Antibody | Mouse anti-porcine cereal Valley virus monoclonal antibodies |
Resource (expression host) | hybridoma |
Specics/Isotypes | Mouse IgG |
Bioactivity validation | Antibody Binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays in porcine cereal Valley virus level test and Pig-diagnositcs. |
Antigen description | GP50, a Taenia solium protein diagnostic for cysticercosis has been cloned, sequenced, and characterized. GP50 is one diagnostic component of the lentil lectin purified glycoprotein (LLGP) antigens that have been used for antibody-based diagnosis of cysticercosis in a Western blot assay for nearly 15 years. GP50 is a glycosylated and GPI-anchored membrane protein. The native protein migrates at 50kDa, but the predicted molecular weight of the mature protein is 28.9. Antigenically active recombinant GP50 has been expressed in a baculovirus expression system. The antigenic activity of both the native and recombinant proteins is dependent upon the correct formation of disulfide bonds. GP50, purified from cysticerci, has two homologs expressed in the adult worm, TSES33 and TSES38. Both are diagnostic for taeniasis. In spite of the amino acid similarities between GP50 and the TSES proteins, each appears to be a stage-specific antigen. A preliminary evaluation of recombinant GP50 in a Western blot assay showed 100% specificity for cysticercosis and 90% sensitivity for cysticercosis positive serum samples reactive with the GP50 component of LLGP |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, Lateral flow immunoassay (LFIA), and other immunoassays; |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. | GMP-AD-Pig-16Ag |
Antigens | porcine cereal Valley virus |
Resource (expression host) | E.coli |
Specics/Isotypes | porcine cereal Valley virus |
Bioactivity validation | Antibody Binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays in porcine cereal Valley virus level test and Pig-diagnositcs. |
Tag | His |
Antigen description | GP50, a Taenia solium protein diagnostic for cysticercosis has been cloned, sequenced, and characterized. GP50 is one diagnostic component of the lentil lectin purified glycoprotein (LLGP) antigens that have been used for antibody-based diagnosis of cysticercosis in a Western blot assay for nearly 15 years. GP50 is a glycosylated and GPI-anchored membrane protein. The native protein migrates at 50kDa, but the predicted molecular weight of the mature protein is 28.9. Antigenically active recombinant GP50 has been expressed in a baculovirus expression system. The antigenic activity of both the native and recombinant proteins is dependent upon the correct formation of disulfide bonds. GP50, purified from cysticerci, has two homologs expressed in the adult worm, TSES33 and TSES38. Both are diagnostic for taeniasis. In spite of the amino acid similarities between GP50 and the TSES proteins, each appears to be a stage-specific antigen. A preliminary evaluation of recombinant GP50 in a Western blot assay showed 100% specificity for cysticercosis and 90% sensitivity for cysticercosis positive serum samples reactive with the GP50 component of LLGP |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, Lateral flow immunoassay (LFIA), and other immunoassays; |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -144℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
- GENEMEDI
- Email: [email protected] [email protected]
- Telephone: +86-21-50478399 Fax: 86-21-50478399
- Privacy Policy
- TECHNICAL SUPPORT
- Product FAQs
- Technical manuals
- Publications
- Email: [email protected]
![](/images/gototop.png)
![](https://www.genemedi.net/images/ad.png)